Management of Hyperkalemia

Immediate Risk Assessment

Obtain an ECG immediately to assess for cardiac conduction abnormalities in elderly patients with potassium levels of 5.6 mEq/L, as they are at higher risk for cardiotoxicity, according to the American Heart Association 1
Verify that the hyperkalemia is not pseudohyperkalemia from hemolysis by repeating the test if there was difficult blood draw or prolonged tourniquet time, as recommended by medical guidelines 2
Elderly patients are particularly vulnerable due to reduced renal function, which may not be reflected in serum creatinine alone, so verify actual GFR or creatinine clearance, as suggested by the American College of Cardiology 1, 3

Immediately discontinue potassium supplements and potassium-sparing diuretics if the patient is taking them, as recommended by the American Heart Association 1
Hold aldosterone antagonists temporarily until potassium normalizes below 5.0 mEq/L, according to the American College of Cardiology 3, 1
Reduce ACE inhibitor or ARB dose by 50% rather than complete discontinuation to maintain cardioprotective benefits, as suggested by medical guidelines 2, 1

Implement strict dietary potassium restriction to <3 g/day (77 mEq/day) by eliminating high-potassium foods, as recommended by the American Heart Association 2

If ECG shows any changes, treat as a cardiac emergency with IV calcium gluconate 15-30 mL over 2-5 minutes, according to the American College of Cardiology 1
If potassium rises to >6.0 mEq/L, temporarily discontinue all RAAS inhibitors completely and administer insulin 10 units IV with 25g dextrose, as recommended by medical guidelines 1, 2

Recheck potassium within 24-72 hours after intervention, not the standard 4-month interval, as suggested by the American Heart Association 2
Monitor blood glucose if insulin is administered, checking within 1-2 hours and every 2-4 hours thereafter, according to medical guidelines 1

The mortality risk at 5.6 mEq/L is significantly higher in elderly patients with comorbidities compared to younger patients, as reported by the Mayo Clinic 4, 2
Elderly patients with diabetes and chronic kidney disease face dramatically increased risk, warranting more aggressive monitoring every 2-4 weeks initially, according to the American Diabetes Association 2, 1

Aim to maintain potassium ≤5.0 mEq/L, as emerging evidence suggests levels >5.0 mEq/L are associated with increased mortality, especially in patients with heart failure, CKD, or diabetes, as recommended by the American Heart Association 2
The optimal range is narrower than traditionally believed: target 4.0-5.0 mEq/L rather than the traditional 3.5-5.5 mEq/L, according to the American College of Cardiology 2, 4

Do not prematurely discontinue ACE inhibitors/ARBs completely—dose reduction is preferred over discontinuation to maintain cardioprotective benefits unless potassium exceeds 6.0 mEq/L, as recommended by the American Heart Association 2, 1
Do not rely on serum creatinine alone in elderly patients to assess renal function—calculate actual creatinine clearance, according to the American College of Cardiology 3, 1

If hyperkalemia persists despite dietary measures and medication adjustments, consider newer potassium binders to enable continuation of beneficial RAAS inhibitor therapy, as suggested by medical guidelines 1, 2